Mayo Clinic Laboratory and Pathology Research Roundup: January 9
Share this:
The research roundup provides an overview of the past week’s research from Mayo Clinic Laboratories consultants, including featured abstracts and a complete list of published studies and reviews.
Featured Abstract
Anakinra-associated systemic amyloidosis.
To describe a 41-year-old woman with a history of neonatal onset multisystem inflammatory disease, on treatment with daily subcutaneous injections of 600 mg of recombinant interleukin-1 receptor antagonist (IL-1Ra) protein, anakinra, since the age of 28, who presented with golf-ball size nodules at the anakinra injection sites, early satiety, new onset nephrotic syndrome in the context of normal markers of systemic inflammation.
Published to PubMed This Week
- Breast cancer polygenic risk score influence on risk-reducing endocrine therapy use: Genetic risk estimate (GENRE) trial 1-year and 2-year follow-up.
Cancer Prevention Research - The evolving role of artificial intelligence in gastrointestinal histopathology: An update.
Clinical Gastroenterology and Hepatology - Genomic and evolutionary characterization of concurrent intraductal carcinoma and adenocarcinoma of the prostate.
Cancer Research - Seventy-five years of service: an overview of the College of American Pathologists' proficiency testing program in histocompatibility and identity testing.
Frontiers in Genetics - At-home molecular diagnostics: Just around the corner or years away?
The Journal of Applied Laboratory Medicine
